Navigation Links
Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
Date:4/29/2008

erty and equipment, net 8,228 7,146

Long-term investments 24,668 -

Other noncurrent assets 1,451 1,441

Total assets $160,334 $149,844

Liabilities and stockholders' equity:

Accounts payable and accrued expenses $22,779 $20,790

Amounts due to related parties 4,513 2,311

Deferred revenue 3,199 3,939

Capital lease obligations 472 485

Total current liabilities 30,963 27,525

Capital lease obligations, net of current

portion 689 794

Deferred revenue, net of current portion 473 421

Other long-term liabilities 240 226

Total stockholders' equity 127,969 120,878

Total liabilities and stockholders' equity $160,334 $149,844

To supplement our consolidated financial statements presented in

accordance with GAAP, Cynosure uses the following measures defined as

non-GAAP financial measures by the SEC: non-GAAP gross profit, non-GAAP

income from operations, non-GAAP net income and non-GAAP diluted earnings

per share. The presentation of this financial information is not intended

to be considered in isolation or as a substitute for the financial

information prepared and presented in accordance with GAAP. In addition,

the non-GAAP financial measures included in this press release may be

different from, and therefore not comparable to, similar measures used by

other companies. Although certain non-GAAP financial measures used in this

release exclude the accounting
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- , - Results From a ... Arthritis in Seven Major Industrialized Countries , , ... say their disease, impacts their ... living with rheumatoid arthritis find shopping for gifts, ... presents most, difficult to do, ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... new explanation for differences in the severity of mental illness ... the more serious the handicap. The genetic defect is situated ... the amount of copies of the GDI1 gene that is ... Journal of Human Genetics , and are the result of ... a life sciences research institute in Flanders, Belgium at the ...
(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...
Breaking Biology Technology:Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... the CDC,s National ... Influenza Virus Vaccine, INDIANAPOLIS, Feb. 11 Sentry ... & Prevention (CDC),signed a contract to outsource storage and ... vaccine. Sentry will warehouse and,distribute more than 500,000 vaccine ...
... 11 Replikins Ltd. announced that the,quantitative analysis ... that the current H5N1 cycle is over. Sporadic ... high mortality characteristics,are expected to subside - until ... influenza virus strain begins., 140,000 virus protein ...
... will provide real-world clinical data on the PROMUS(TM) ... Scientific,Corporation (NYSE: BSX ) today announced that ... (PROMUS(TM), ENdeavor(R) and CYpher(R)) European,registry. The registry is ... will collect real-life clinical outcome data for Boston,Scientific,s ...
Other Biology Technology:The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 3FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over 2Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 2Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 3Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 4
(Date:12/14/2009)... clean-burning, renewable fuel that could help wean the nation ... ozone, compared with gasoline, especially in winter, according to ... Ozone production from both gasoline and E85, a blend ... is greater in warm sunny weather than during the ... and sunlight contribute to ozone formation. But E85 produces ...
(Date:12/14/2009)... 2009If you are spending the holidays with big Uncle ... would be better off with another family, spare a ... research team from McMaster University and the University of ... species that lives in groups, members make strategic decisions ... in the current issue of Biology Letters . ...
(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2RainEarth 28RNER 29 Signs Purchase Agreement with HangZhou Municipal No 3 Peoples Hospital 55716 1RainEarth 28RNER 29 Signs Purchase Agreement with HangZhou Municipal No 3 Peoples Hospital 55716 2RainEarth 28RNER 29 Signs Purchase Agreement with HangZhou Municipal No 3 Peoples Hospital 55716 3Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN 28R 29 Over Crinone 28R 29 for Progesterone Supplementation 55712 1Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN 28R 29 Over Crinone 28R 29 for Progesterone Supplementation 55712 2Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN 28R 29 Over Crinone 28R 29 for Progesterone Supplementation 55712 3CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 1CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 3
... literature on transient receptor potential (TRP) channelsion channels ... touch, olfaction, and other sensesvery little is known ... mechanisms that control their gating processes. , In ... http://jgp.rupress.org/current.shtml ), the Journal of General Physiology ...
... WASHINGTON DC, March 25, 2009 - Critically endangered hawksbill ... in the Dominican Republic after a powerful government campaign ... than 99 percent of these souvenirs have been withdrawn ... , A 2006 survey carried out by TRAFFIC ...
... southern Asia drink groundwater contaminated with arsenic. Thousands of ... of cancer each year from chronic exposure to arsenic, ... call it the biggest mass poisoning in history. , ... of the contamination in the Himalaya Mountains, where sediments ...
Other Biology News:Turtles no longer turned into souvenirs 2Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 2Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 3Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 4Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 5Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 6
albumin from bovine serum (BSA), Alexa Fluor® 647 conjugate...
albumin from bovine serum (BSA), BODIPY® FL conjugate...
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
... (human, bovine, porcine, rat) ... receptor antagonist. This carboxy-terminal VIP ... twofold more potent than any ... Storage: ...
Biology Products: